Type I interferons might form the link between Toll-like receptor (TLR) 3/7 and TLR4-mediated synovial inflammation in rheumatoid arthritis (RA)

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Annals of the Rheumatic Diseases

• Publication date

  2008-09-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1136/ard.2007.086421PMID 18765427
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis.

  2008cited by this paper
• The orchestra of Toll-like receptors and their potential role in frequently occurring rheumatic conditions.

  2008cited by this paper
• Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients

  2007cited by this paper
• Interferon-beta

  2007cited by this paper
• Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis.

  2007cited by this paper
• IkappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9.

  2006cited by this paper
• U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7.

  2006cited by this paper
• Identification of Small Heat Shock Protein B8 (HSP22) as a Novel TLR4 Ligand and Potential Involvement in the Pathogenesis of Rheumatoid Arthritis1

  2006cited by this paper
• IκB kinase-α is critical for interferon-α production induced by Toll-like receptors 7 and 9

  2006cited by this paper
• Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8

  2005cited by this paper
• Cutting Edge: TLR Ligands Are Not Sufficient to Break Cross-Tolerance to Self-Antigens1

  2005cited by this paper
• RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3.

  2005cited by this paper
• Influence of human cytomegalovirus on immune reconstitution after bone marrow transplantation

  2005cited by this paper
• The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells.

  2005cited by this paper
• Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1–polarizing program in dendritic cells

  2005cited by this paper
• Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis

  2004cited by this paper
• Recognition of single-stranded RNA viruses by Toll-like receptor 7.

  2004cited by this paper
• Arthritogenic Properties of Double-Stranded (Viral) RNA1

  2004cited by this paper
• A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis

  2004cited by this paper
• Treatment with recombinant interferon-β reduces inflammation and slows cartilage destruction in the collagen-induced arthritis model of rheumatoid arthritis

  2004cited by this paper
• Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma.

  2004cited by this paper
• Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis.

  2003cited by this paper
• A randomized, controlled trial of interferon-β-1a (Avonex®) in patients with rheumatoid arthritis: a pilot study [ISRCTN03626626]

  2003cited by this paper
• Simultaneous Detection of 15 Human Cytokines in a Single Sample of Stimulated Peripheral Blood Mononuclear Cells

  2003cited by this paper
• Oligosaccharides of Hyaluronan Activate Dendritic Cells via Toll-like Receptor 4

  2002cited by this paper
• Interferons α and β as Immune Regulators—A New Look

  2001cited by this paper
• Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3

  2001cited by this paper
• The Extra Domain A of Fibronectin Activates Toll-like Receptor 4*

  2001cited by this paper
• Interferons alpha and beta as immune regulators--a new look.

  2001cited by this paper
• Cutting Edge: Heat Shock Protein 60 Is a Putative Endogenous Ligand of the Toll-Like Receptor-4 Complex1

  2000cited by this paper
• Synovial Epstein-Barr virus infection increases the risk of rheumatoid arthritis in individuals with the shared HLA-DR4 epitope.

  1999cited by this paper
• Human parvovirus B19 as a causative agent for rheumatoid arthritis.

  1998cited by this paper
• Demonstration of cytomegalovirus (CMV) DNA and anti-CMV response in the synovial membrane and serum of patients with rheumatoid arthritis.

  1992cited by this paper
• Revised criteria for the classification of rheumatoid arthritis.

  1990cited by this paper
• Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.

  1988cited by this paper
• The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

  1988influential reference
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Preliminary criteria for the classification of systemic sclerosis (scleroderma).

  1980cited by this paper
• Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

  1980cited by this paper
• randomized controlled

  year unknowncited by this paper

• Tm4sf19 inhibition ameliorates inflammation and bone destruction in collagen-induced arthritis by suppressing TLR4-mediated inflammatory signaling and abnormal osteoclast activation

  2025cites this paper
• The Type I Interferon Axis in Systemic Autoimmune Diseases: From Molecular Pathways to Targeted Therapy

  2025cites this paper
• Plasma Pro‐ and Anti‐Inflammatory Cytokines in an Observational Chronic Low Back Pain Cohort

  2025cites this paper
• Type I Interferons in health and disease-Molecular aspects and clinical implications.

  2025cites this paper
• Anti-inflammatory effects of phytocannabinoids and terpenes on inflamed Tregs and Th17 cells in vitro.

  2024cites this paper
• Regulation of human interferon signaling by transposon exonization.

  2024cites this paper
• Target Role of Monocytes as Key Cells of Innate Immunity in Rheumatoid Arthritis

  2024cites this paper
• Exploring precision treatments in immune‐mediated inflammatory diseases: Harnessing the infinite potential of nucleic acid delivery

  2024cites this paper
• Type I Interferons in Systemic Autoimmune Rheumatic Diseases: Pathogenesis, Clinical Features and Treatment Options

  2024cites this paper
• Autoimmunity: A New Focus on Nasal Polyps

  2023cites this paper
• Regulation of human interferon signaling by transposon exonization

  2023cites this paper
• HMGB1 and Toll-like receptors: potential therapeutic targets in autoimmune diseases

  2023cites this paper
• Role and Therapeutic Potential for Targeting Fibroblast Growth Factor 10/FGFR1 in Relapsed Rheumatoid Arthritis

  2023cites this paper
• Type I Interferons in Autoimmunity: Implications in Clinical Phenotypes and Treatment Response

  2023cites this paper
• Host Immune Responses to Arthritogenic Alphavirus Infection, with Emphasis on Type I IFN Responses

  2022cites this paper
• Platelet signaling at the nexus of innate immunity and rheumatoid arthritis

  2022cites this paper
• Pathway Phenotypes Underpinning Depression, Anxiety, and Chronic Fatigue Symptoms Due to Acute Rheumatoid Arthritis: A Precision Nomothetic Psychiatry Analysis

  2022cites this paper
• Marked increase of interferon-β after BNT162b2 mRNA vaccination: a case of polyarthritis with pleurisy

  2022cites this paper
• Myasthenia Gravis: An Acquired Interferonopathy?

  2022cites this paper
• Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity

  2022cites this paper
• Depression, anxiety, and chronic fatigue symptoms in acute rheumatoid arthritis are associated with immune-inflammatory, autoimmune, endogenous opioid system and lactosylceramide signaling pathways: a nomothetic network approach.

  2021cites this paper
• Type I Interferons in Systemic Autoimmune Diseases: Distinguishing Between Afferent and Efferent Functions for Precision Medicine and Individualized Treatment

  2021cites this paper
• Type I interferon detection in autoimmune diseases: challenges and clinical applications

  2021cites this paper
• Will rheumatologists ever pick up the arthroscope again?

  2021cites this paper
• A comprehensive transcriptomic analysis of alternate interferon signaling pathways in peripheral blood mononuclear cells in rheumatoid arthritis

  2021cites this paper
• Innate immunity drives pathogenesis of rheumatoid arthritis

  2020cites this paper
• A peptide derived from the core β-sheet region of TIRAP decoys TLR4 and reduces inflammatory and autoimmune symptoms in murine models

  2020cites this paper
• Roles of Interactions Between Toll-Like Receptors and Their Endogenous Ligands in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still’s Disease

  2020influential citation
• Scientific validation of anti-arthritic effect of Kashayams – A polyherbal formulation in collagen induced arthritic rats

  2019cites this paper
• FC-99 reduces macrophage tenascin-C expression by upregulating miRNA-494 in arthritis.

  2019cites this paper
• Linear and Rationally Designed Stapled Peptides Abrogate TLR4 Pathway and Relieve Inflammatory Symptoms in Rheumatoid Arthritis Rat Model.

  2019cites this paper
• Type I interferons in host defence and inflammatory diseases

  2019cites this paper
• Expression and function of miR-155 in rat synovial fibroblast model of rheumatoid arthritis.

  2019cites this paper
• Induction of pro-inflammatory cytokines by 29-kDa FN-f via cGAS/STING pathway

  2019cites this paper
• Revealing synergistic mechanism of multiple components in compound Fengshiding capsule for rheumatoid arthritis therapeutics by network pharmacology.

  2019cites this paper
• Toll‐like receptors 7 and 9 in myasthenia gravis thymus: amplifiers of autoimmunity?

  2018cites this paper
• Genetic deletion of GIT2 prolongs functional recovery and suppresses chondrocyte differentiation in rats with rheumatoid arthritis

  2018cites this paper
• TNF‑α increases inflammatory factor expression in synovial fibroblasts through the toll‑like receptor‑3‑mediated ERK/AKT signaling pathway in a mouse model of rheumatoid arthritis.

  2018cites this paper
• Type I interferon in rheumatic diseases

  2018cites this paper
• Interferon alpha: The key trigger of type 1 diabetes.

  2018cites this paper
• TLRs, future potential therapeutic targets for RA.

  2017cites this paper
• JAK‐inhibitor tofacitinib suppresses interferon alfa production by plasmacytoid dendritic cells and inhibits arthrogenic and antiviral effects of interferon alfa

  2017cites this paper
• Dysregulation of signaling pathways associated with innate antibacterial immunity in patients with pancreatic cancer

  2017cites this paper
• Direct recognition of LPS drive TLR4 expressing CD8+ T cell activation in patients with rheumatoid arthritis

  2017cites this paper
• Circular RNA expression profiles of peripheral blood mononuclear cells in rheumatoid arthritis patients, based on microarray chip technology

  2017cites this paper
• Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection.

  2016cites this paper
• Toll-Like Receptor Pathways in Autoimmune Diseases

  2016cites this paper
• Роль Toll-подобных рецепторов и их эндогенных лигандов в патогенезе ревматоидного артрита (обзор литературы)

  2016cites this paper
• Immunological Biomarkers for Patient Stratification

  2016cites this paper
• U1-RNP and Toll-like receptors in the pathogenesis of mixed connective tissue diseasePart II. Endosomal TLRs and their biological significance in the pathogenesis of mixed connective tissue disease

  2015cites this paper
• Inhibiting Notch-1 reduces the expression of Toll-like receptor 9 in BABL/C-lpr mouse kidneys and improves glucocorticoid sensitivity.

  2015cites this paper
• Investigating the impact of chronic inflammation on monocyte function in HIV+ individuals and the elderly

  2015cites this paper
• Type I IFNs as biomarkers in rheumatoid arthritis: towards disease profiling and personalized medicine.

  2015cites this paper
• Immune tolerance by interferon-alpha in experimental arthritis

  2015cites this paper
• Effect of Poli I:C in murine model of autoimmune thyroiditis

  2015cites this paper
• Pristane primed rat T cells enhance TLR3 expression of fibroblast-like synoviocytes via TNF-α initiated p38 MAPK and NF-κB pathways.

  2015cites this paper
• IL-29 Enhances LPS/TLR4-Mediated Inflammation in Rheumatoid Arthritis

  2015cites this paper
• Toll-like receptor (TLR)-3: a potent driving force behind rheumatoid arthritis

  2014cites this paper
• Increased expression of Toll-like receptors (TLRs) 7 and 9 and other cytokines in systemic lupus erythematosus (SLE) patients: ethnic differences and potential new targets for therapeutic drugs.

  2014cites this paper
• MicroRNA-26a negatively regulates toll-like receptor 3 expression of rat macrophages and ameliorates pristane induced arthritis in rats

  2014cites this paper
• Understanding IFNλ in rheumatoid arthritis

  2014cites this paper
• Gene expression disorders of innate antibacterial signaling pathway in pancreatic cancer patients: implications for leukocyte dysfunction and tumor progression

  2014cites this paper
• The role of miRNA in inflammation and autoimmunity.

  2013cites this paper
• T Cell CD3ζ Deficiency Enables Multiorgan Tissue Inflammation

  2013cites this paper
• Activated Protein C Inhibits Proliferation and Tumor Necrosis Factor α-Stimulated Activation of p38, c-Jun NH2-Terminal Kinase (JNK) and Akt in Rheumatoid Synovial Fibroblasts

  2013cites this paper
• Inflammatory immune cell responses and Toll-like receptor expression in synovial tissues in rheumatoid arthritis patients treated with biologics or DMARDs

  2013cites this paper
• Toll-like receptors as therapeutic targets for autoimmune connective tissue diseases.

  2013cites this paper
• IL-29 enhances Toll-like receptor-mediated IL-6 and IL-8 production by the synovial fibroblasts from rheumatoid arthritis patients

  2013cites this paper
• Plasmacytoid dendritic cells: biomarkers or potential therapeutic targets in atherosclerosis?

  2013cites this paper
• Reactive oxygen species in inflammation

  2013cites this paper
• Activated Protein C Inhibits Proliferation and Tumor Necrosis Factor α – Stimulated Activation of p 38 , c-Jun NH 2-Terminal Kinase ( JNK ) and Akt in Rheumatoid Synovial Fibroblasts

  2013cites this paper
• Investigation of the role of endosomal Toll-like receptors in murine collagen-induced arthritis reveals a potential role for TLR7 in disease maintenance

  2012cites this paper
• Genetic studies of non-HLA loci in rheumatoid arthritis : expression and interaction of candidate genes

  2012cites this paper
• The role of Toll-like receptors in health and disease - short review

  2012cites this paper
• Innate Immunity in Rheumatoid and Psoriatic Arthritis. Toll-like Receptors as Mediators of Disease

  2012cites this paper
• Targeting DAMP Activation of Toll-Like Receptors: Novel Pathways to Treat Rheumatoid Arthritis?

  2012cites this paper
• Enhancement of antibody-induced arthritis via Toll-like receptor 2 stimulation is regulated by granulocyte reactive oxygen species.

  2012cites this paper
• Overexpression of Toll‐Like Receptor 3 in Spleen is Associated with Experimental Arthritis in Rats

  2012cites this paper
• Possible Involvement of Toll-Like Receptors in the Pathogenesis of Myasthenia Gravis

  2012cites this paper
• RNA sensors in human osteoarthritis and rheumatoid arthritis synovial fibroblasts: immune regulation by vasoactive intestinal peptide.

  2011cites this paper
• Hyaluronan reduces inflammation in experimental arthritis by modulating TLR-2 and TLR-4 cartilage expression.

  2011cites this paper
• Interferon Alpha as a Primary Pathogenic Factor in Human Lupus

  2011cites this paper
• Suppression of collagen-induced arthritis by intra-articular lentiviral vector-mediated delivery of Toll-like receptor 7 short hairpin RNA gene

  2011cites this paper
• Toll-like receptor 3 upregulation by type I interferon in healthy and scleroderma dermal fibroblasts

  2011cites this paper
• Toll‐like receptors in rheumatic diseases: Are we paying a high price for our defense against bugs?

  2011cites this paper
• Toll Like Receptors Signaling Pathways as a Target for Therapeutic Interventions.

  2011cites this paper
• Toll-like receptor 3 ligand polyinosinic:polycytidylic acid enhances autoimmune disease in a retinal autoimmunity model.

  2011cites this paper
• Effects of age, gender, and immunosuppressive agents on in vivo toll-like receptor pathway responses.

  2010cites this paper
• The type I IFN system in rheumatoid arthritis

  2010cites this paper
• Toll‐like receptor signaling: a potential link among rheumatoid arthritis, systemic lupus, and atherosclerosis

  2010cites this paper
• Innate immunity and rheumatoid arthritis.

  2010cites this paper
• Sensors of the innate immune system: their link to rheumatic diseases

  2010cites this paper
• Toll-like receptor (TLR) expression on CD4+ and CD8+ T-cells in patients chronically infected with hepatitis C virus.

  2010cites this paper
• Genetic regulation of serum cytokines in systemic lupus erythematosus.

  2010cites this paper
• Targeting Toll-Like Receptors for Treatment of SLE

  2010cites this paper
• Fluoxetine and citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll-like receptors.

  2010cites this paper
• Rheumatoid arthritis progression mediated by activated synovial fibroblasts.

  2010cites this paper
• Antigen-Presenting Cells and their Fcγ and Toll-Like Receptors: Leading Suspects in Autoimmunity

  2010cites this paper
• Functional consequences of DECTIN-1 early stop codon polymorphism Y238X in rheumatoid arthritis

  2010cites this paper
• Type I interferons in systemic autoimmunity

  2010cites this paper